Enterin Inc. is a clinical-stage biopharmaceutical company pioneering novel treatments that target the gut-brain axis and modify the course of neurodegenerative disorders. Our research has aided the scientific community in understanding the link between infection and the role of the enteric nervous system (ENS) in immune defense. As a result of repeated insults to the gastrointestinal tract (GIT), neural communication between ...
Enterin Inc. is a clinical-stage biopharmaceutical company pioneering novel treatments that target the gut-brain axis and modify the course of neurodegenerative disorders. Our research has aided the scientific community in understanding the link between infection and the role of the enteric nervous system (ENS) in immune defense. As a result of repeated insults to the gastrointestinal tract (GIT), neural communication between the ENS and the central nervous system (CNS) is progressively impaired. Our work has clarified the relationship between immune defense, the ageing process, and the progression of neurodegeneration.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.